Literature DB >> 33787988

Phytochemical characterization and inhibition of Candida sp. by the essential oil of Baccharis trimera (Less.) DC.

Taís Gusmão da Silva1, Josefa Carolaine Pereira da Silva1, Joara Nályda Pereira Carneiro1, Wanderlei do Amaral2, Cícero Deschamps2, Jenifer Priscila de Araújo2, José Galberto Martins da Costa1, Waltécio de Oliveira Almeida1, Luiz Everson da Silva2, Henrique Douglas Melo Coutinho3, Jaime Ribeiro Filho4, Maria Flaviana Bezerra Morais-Braga1.   

Abstract

This study aimed to investigate the chemical composition and antifungal potential of the essential oil of Baccharis trimera (Less.) DC. against Candida strains. The half maximal inhibitory concentration (IC50) was assessed by the microdilution method using the essential oil at a concentration range of 8192 to 8 μg/mL. The minimum fungicide concentration (MFC) was determined by subculture in solid medium. The ability of the essential oil to modulate the activity of antifungals was determined in wells treated simultaneously with the oil at a subinhibitory concentration (MFC/16) and fluconazole (FCZ). The fungal morphology was analyzed by microscopy. Gas chromatography coupled with mass spectrometry (GC/MS) was used to identify the chemical composition. The essential oil presented an CI50 of 11.24 and 1.45 μg/mL, which was found to potentiate the effect of FCZ against Candida albicans. On the other hand, this combined treatment resulted in antagonism against Candida tropicalis and no evident modulation against Candida krusei was observed. The essential oil significantly inhibited hyphae growth. However, with a MFC ≥ 16,384 μg/mL, it is assumed that it has a fungistatic action. The antifungal properties demonstrated in this study might be related to the presence of sesquiterpenes and monoterpenes, and the interaction between them. In conclusion, Baccharis trimera showed promising anti-Candida effects, in addition to potentiating the activity of FCZ against Candida albicans, affecting its morphological transition. Therefore, this species constitutes a source of chemical compounds with the potential to be used in the combat of fungal infections.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Anti-Candida effect; Baccharis trimera; Essential oils; Terpenes

Year:  2021        PMID: 33787988     DOI: 10.1007/s00203-021-02304-8

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  14 in total

1.  Characterization of red wines from South America based on sensory properties and antioxidant activity.

Authors:  Daniel Granato; Flávia Chizuko Uchida Katayama; Inar Alves de Castro
Journal:  J Sci Food Agric       Date:  2011-10-03       Impact factor: 3.638

2.  [Mycological aspects and susceptibility in vitro the yeast of the genus Candida from HIV-positive patients in the State of Mato Grosso].

Authors:  Olivia Cometti Favalessa; Marilena dos Anjos Martins; Rosane Christine Hahn
Journal:  Rev Soc Bras Med Trop       Date:  2010 Nov-Dec       Impact factor: 1.581

Review 3.  Uses and abuses of in vitro tests in ethnopharmacology: visualizing an elephant.

Authors:  P J Houghton; M-J Howes; C C Lee; G Steventon
Journal:  J Ethnopharmacol       Date:  2007-01-31       Impact factor: 4.360

Review 4.  Candida albicans hyphal initiation and elongation.

Authors:  Yang Lu; Chang Su; Haoping Liu
Journal:  Trends Microbiol       Date:  2014-09-25       Impact factor: 17.079

Review 5.  Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?

Authors:  Danièle Maubon; Cécile Garnaud; Thierry Calandra; Dominique Sanglard; Muriel Cornet
Journal:  Intensive Care Med       Date:  2014-08-05       Impact factor: 17.440

6.  Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.

Authors:  A Espinel-Ingroff; M A Pfaller; B Bustamante; E Canton; A Fothergill; J Fuller; G M Gonzalez; C Lass-Flörl; S R Lockhart; E Martin-Mazuelos; J F Meis; M S C Melhem; L Ostrosky-Zeichner; T Pelaez; M W Szeszs; G St-Germain; L X Bonfietti; J Guarro; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

7.  In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods.

Authors:  E J Ernst; M E Klepser; M E Ernst; S A Messer; M A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  1999-02       Impact factor: 2.803

8.  Evaluation of extracts and oils of tick-repellent plants from Sweden.

Authors:  T G T Jaenson; K Pålsson; A-K Borg-Karlson
Journal:  Med Vet Entomol       Date:  2005-12       Impact factor: 2.739

9.  De novo antimicrobial peptides with low mammalian cell toxicity.

Authors:  M M Javadpour; M M Juban; W C Lo; S M Bishop; J B Alberty; S M Cowell; C L Becker; M L McLaughlin
Journal:  J Med Chem       Date:  1996-08-02       Impact factor: 7.446

10.  Antimicrobial Activity of Essential Oil of Baccharis dracunculifolia DC (Asteraceae) Aerial Parts at Flowering Period.

Authors:  Luciane Neris Cazella; Jasmina Glamoclija; Marina Soković; José Eduardo Gonçalves; Giani Andrea Linde; Nelson Barros Colauto; Zilda Cristiani Gazim
Journal:  Front Plant Sci       Date:  2019-01-29       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.